Genetic variants of NQO1 affect the expression and activity of the protein, which determines the efficacy of idebenone treatment in Leber's hereditary optic neuropathy

被引:0
|
作者
Del Dotto, Valentina [1 ]
Aleo, Serena J. [1 ]
Romagnoli, Martina [1 ]
Fiorini, Claudio [1 ]
Capirossi, Giada [2 ]
Peron, Camille [3 ]
Fasano, Chiara [3 ]
Maresca, Alessandra [1 ]
Caporali, Leonardo [1 ]
Capristo, Mariantonietta [1 ]
Tropeano, Concetta V. [1 ]
Zanna, Claudia [2 ]
Porcelli, Anna M. [4 ]
Tioli, Gaia [4 ]
Amore, Giulia [2 ]
La Morgia, Chiara [1 ,2 ]
Tiranti, Valeria [3 ]
Carelli, Valerio [1 ,2 ]
Ghelli, Anna [1 ,4 ]
机构
[1] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
[2] IRCCS Ist Sci Neurol Bologna, Programma Neurogenet, Bologna, Italy
[3] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy
[4] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy
关键词
D O I
10.1016/j.bbabio.2024.149470
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T23 P-4
引用
收藏
页码:137 / 137
页数:1
相关论文
共 32 条
  • [21] Efficacy and Safety of rAAV2-ND4 Treatment for Leber's Hereditary Optic Neuropathy
    Wan, Xing
    Pei, Han
    Zhao, Min-Jian
    Yang, Shuo
    Hu, Wei-kun
    He, Heng
    Ma, Si-qi
    Zhang, Ge
    Dong, Xiao-yan
    Chen, Chen
    Wang, Dao-wen
    Li, Bin
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Visual function in chronic Leber’s hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset
    Berthold Pemp
    Karl Kircher
    Andreas Reitner
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 2751 - 2757
  • [23] Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset
    Pemp, Berthold
    Kircher, Karl
    Reitner, Andreas
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (12) : 2751 - 2757
  • [24] The Evaluation of Optic Nerves Using 7 Tesla "Silent" Zero Echo Time Imaging in Patients with Leber's Hereditary Optic Neuropathy with or without Idebenone Treatment
    Grochowski, Cezary
    Symms, Mark
    Jonak, Kamil
    Krukow, Pawel
    Wood, Tobias C.
    Ljungberg, Emil
    Ensenat, Joaquim
    Nowomiejska, Katarzyna
    Rejdak, Robert
    Maciejewski, Ryszard
    Barker, Gareth J.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [25] Changes in Visual Function and Correlations with Inner Retinal Structure in Acute and Chronic Leber's Hereditary Optic Neuropathy Patients after Treatment with Idebenone
    Pemp, Berthold
    Mitsch, Christoph
    Kircher, Karl
    Reitner, Andreas
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 13
  • [26] Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy-Response to Dr. Finsterer's Letter
    Catarino, Claudia B.
    von Livonius, Bettina
    Priglinger, Claudia
    Landau, Klara
    Newman, Nancy J.
    Votruba, Marcela
    Rudolph, Guenther
    Klopstock, Thomas
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2023, 43 (03) : E96 - E96
  • [27] Leber's hereditary optic neuropathy: Heteroplasmy is likely to be significant in the expression of LHON in families with the 3460 ND1 mutation
    Black, GCM
    Morten, K
    Laborde, A
    Poulton, J
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (10) : 915 - 917
  • [28] Long-term efficacy and safety of idebenone in patients with Leber's hereditary optic neuropathy (LHON) in the subacute/dynamic phase: Results from the prospective, natural historycontrolled LEROS study
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Tomasso, Livia
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [29] Long-term efficacy and safety of idebenone in patients with Leber's hereditary optic neuropathy (LHON) in the chronic phase: Results from the prospective, natural history-controlled LEROS study
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Tomasso, Livia
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [30] Assessing the impact of long-term idebenone treatment on various visual acuity outcomes in Leber's hereditary optic neuropathy (LHON): Results, according to disease stage, from the prospective, natural historycontrolled LEROS study
    Tomasso, Livia
    Carelli, Valerio
    Yu-Wai-Man, Patrick
    Klopstock, Thomas
    ACTA OPHTHALMOLOGICA, 2022, 100